April 21, 2026
According to market projections, small molecule inhibitor market was valued at USD 310.38 billion in 2025 and is expected to reach USD 328.22 billion by 2026, further expanding to around USD 542.87 billion by 2035, growing at a CAGR of 5.75% from 202...
April 21, 2026
According to market projections, the small molecule API sector is expected to grow from USD 206.9 billion in 2025 to USD 374.03 billion by 2035, reflecting a CAGR of 6.1%. The small molecule API market is growing due to rising investment by key playe...
April 21, 2026
The GLP-1 small molecule market covers comprehensive insights on global market size, segmentation, regional performance, and competitive dynamics across North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. The market ...
February 11, 2026
According to our projections, the global small molecule CMC service market was valued at USD 801.3 million in 2025 and reached USD 831.35 million in 2026, and it is projected to expand to approximately USD 1,157.91 million by 2035, growing at a CAGR ...
June 16, 2026
According to Rohan Patil, who specializes in pharmaceutical CDMO, life sciences, and healthcare market analysis, with 5+ years of experience in market research and industry analysis, his research reveals that the U.S. Small Molecule Innovator API CDM...
July 09, 2026
Forecasts suggest that the small molecule CDMO market will expand from USD 83.58 billion in 2026 to USD 155.48 billion by 2035, with a CAGR of 7.14% during this period. In 2024, North America led the small molecule CDMO market, with APIs holding the ...
July 20, 2026
According to Payal Rabde, who specializes in Target identification and validation, lead optimization and candidate selection, and high-throughput screening, with 4+ years of experience in market research and industry analysis, extensive research indi...
July 10, 2026
According to Rohan Patil, who specializes in small molecule drug development and manufacturing, API manufacturing solutions, Contract research and manufacturing services, and end-to-end manufacturing services, with 5+ years of experience in market re...
July 13, 2026
According to Rohan Patil, who specializes in healthcare services, medical outsourcing, and CDMO services provided in healthcare and pharmaceuticals, with 5+ years of experience in market research and industry analysis, extensive research indicates st...
April 21, 2026
Projections indicate that, small nucleic acid drug industry is projected to rise from USD 5.94 billion in 2024 to USD 33.28 billion by 2034, reflecting a CAGR of 18.84% over the next decade. The rising prevalence of chronic disorders and the growing ...
May 22, 2026
Small Molecules Market (By Product Lifecycle: Patented/Innovator Small-Molecule Brands, Generics, OTC/Non-prescription; By Therapeutic Area: Oncology, Cardiometabolic, CNS/Psychiatry & Neurology, Infectious Diseases, Respiratory & Allergy, Ga...
July 14, 2026
According to Rohan Patil, who specializes in life sciences with extensive expertise in cell and gene therapy, corporate strategy formulation, and commercial pipeline evaluation, with 5+ years of experience in market research and industry analysis, ex...
July 15, 2026
Market insights predict the global small scale bioreactors industry will increase from USD 2.63 billion in 2025 to USD 10.49 billion by 2035, achieving a CAGR of 14.84%. The growing demand for biopharmaceuticals and technological advancements drives ...
April 21, 2026
Market insights predict, the non-small cell lung cancer therapeutics industry is expected to grow from USD 21.5 billion in 2024 to USD 71.2 billion by 2034, driven by a CAGR of 12.74%. The non-small cell lung cancer therapeutics market is expanding d...
April 21, 2026
Market insights predict the global non-small lung carcinoma industry will increase from USD 9.1 billion in 2024 to USD 23.67 billion by 2034, achieving a CAGR of 10.03%. Clinical research, development of new treatment options, and prevalence of NSCLC...
April 21, 2026
The IVD diagnostic molecule raw enzymes market is valued at USD 2.39 billion in 2024, projected to reach USD 4.73 billion by 2034 at a 7.13% CAGR. It includes segmentation by enzyme type, application, and technology, with leading regions like North A...
April 21, 2026
The molecule therapeutics market is growing due to the field of molecular therapeutics is significant in medicine and human biology, as it provides novel information on the discovery, diagnosis, and treatment of present and emerging diseases....
January 21, 2026
Based on our market forecasts, the hemophilia inhibitors sector will expand from USD 16.43 billion in 2025 to USD 29.54 billion by 2035, experiencing a CAGR of 6.04%....
February 04, 2026
According to market research studies, the global oral Factor Xa inhibitors market was valued at USD 21.5B in 2023 and is projected to reach USD 41.24B by 2034, growing at a CAGR of 6.1%, driven by rising cardiovascular cases, ease of use, and incre...
July 16, 2026
According to Shivani Zoting, who specializes in oncology therapeutics, cancer immunotherapy, and biopharmaceutical market research, with 5+ years of experience in market research and industry analysis. My research indicates that the immune checkpoint...
January 06, 2026
Based on market forecasts, the bRo5 molecules market is witnessing rapid expansion due to increasing pharmaceutical R&D investments, growing adoption of AI-assisted drug discovery platforms, and rising oncology and CNS disorder prevalence. The ma...
April 24, 2026
Induced Proximity Molecules Market (By Molecule Type: PROTACs, Molecular Glues, LYTACs, AUTACs & ATTECs; By Target Protein Class: Kinases, Transcription Factors, Epigenetic Proteins, GPCRs & Membrane Proteins, Others; By Therapeutic Area: Onc...
July 14, 2026
According to Rohan Patil, who specializes in pharmaceuticals, oncology therapeutics, and advanced clinical pipelines, with 5+ years of experience in market research and industry analysis, extensive research indicates strong growth opportunities in th...
April 21, 2026
According to research analysis, the global Factor Xa inhibitors market, valued at US$ 22.1 billion in 2023, is projected to reach US$ 41.52 billion by 2034, driven by rising cardiovascular diseases. North America leads, while Asia-Pacific shows fas...
April 21, 2026
According to market projections, the CDK4/6 inhibitors sector is expected to grow from USD 11.38 billion in 2024 to USD 46.96 billion by 2034, reflecting a CAGR of 15.34%. The rising prevalence of cancer and growing research and development activit...
+1 9197 992 333
+91 93077 85324
